Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.
Two-day purchase Aug 18–19 via Kelcy Warren Partners LP (indirect). Aug 18: 352,032 units @ $21.27 wtd avg; Aug 19: 647,968 units @ $21.26 wtd avg. Prices ranged $21.175–$21.30. No 10b5-1 plan. Warren now holds ~160.5M total ET units across all vehicles. Current: $21.21 (−0.3% from buy).
Ordinary shares purchased on Buenos Aires exchange; USD prices converted from ARS per Bloomberg rates. Aug 18: 396,950 @ $3.345; Aug 19: 902,975 @ $3.339. Mindlin is controlling shareholder of Argentina's largest integrated energy company. PAM ADR (NYSE) now $79.39, implying ordinary share ≈ $3.18 (−4.7% from buy equivalent).
Three open-market tranches in filing: Aug 18: 93,000 @ $1.7012; Aug 19: 1,619,316 @ $1.66 + 55,000 @ $1.6433. Wtd avg $1.661. Third distinct buying window in ~10 days; total recent accumulation approaching $3.6M. Current: $1.70 (+2.4% from buy).
Six tranches on single day (Aug 20), prices $189.84–$194.48 (wtd avg $193.49), specifically structured to cross 1,000,000-share ownership threshold (now holds 1,000,394 shares direct). Outside any 10b5-1 plan. Current: $194.30 (+0.4% from buy).
Open-market purchase Aug 18 at $1.62 flat; no 10b5-1 plan. CEO now holds 5,971,000 direct shares + 366,000 indirect (spouse). Current: $1.76 (+8.6% from buy). Junior gold play with meaningful CEO conviction buy.
AIThe day in insider buying
SEC Form 4 Insider Scan — August 21, 2026
Scanned the last 24 hours of EDGAR Form 4 filings. 5 qualifying buys (≥ $250K, transaction type P) totalling $33.1M.
Headline Filings
ET — Kelcy L. Warren (Director) bought 1,000,000 units ≈ $21.3M at $21.26 avg; now $21.21 (−0.3% since buy). Two-day open-market purchase via Kelcy Warren Partners LP, no 10b5-1 plan. (filing)
PAM — Marcos Marcelo Mindlin (Director / 10% Owner) bought 1,299,925 ordinary shares ≈ $4.3M at $3.34 avg (USD, converted from ARS); PAM ADR now $79.39 (≈$3.18/ordinary @ ~25:1, approx. −4.7% from buy). (filing)
ENHA — Apeiron Investment Group Ltd. / Christian Angermayer (Director / 10% Owner) bought 1,767,316 shares ≈ $2.9M at $1.661 wtd avg across Aug 18–19; now $1.70 (+2.4% since buy). Third distinct tranche in ~10 days. (filing)
AMR — Kenneth S. Courtis (Director) bought 15,000 shares ≈ $2.9M at $193.49 avg; now $194.30 (+0.4% since buy). Six tranches on one day, precisely engineered to cross the 1,000,000-share ownership threshold. (filing)
IAUX — Richard Scott Young (President & CEO) bought 1,000,000 shares ≈ $1.6M at $1.62; now $1.76 (+8.6% since buy). No 10b5-1 plan; CEO now holds 5,971,000 direct shares. (filing)
Notes
Energy & resources dominate the buy tape. Three of five qualifying transactions touch the energy/mining complex. Kelcy Warren's $21.3M round-number addition to his ~160M-unit ET stake is the standout — he bought exactly 1,000,000 units across two days, a deliberate accumulation signal from Energy Transfer's founder and executive chairman. Marcos Mindlin adds to his Argentine integrated energy holding as Pampa Energía benefits from local currency tailwinds. AMR's Courtis executed six tranches on a single day specifically to cross the 1,000,000-share threshold in the metallurgical coal producer — a choreographed conviction trade.
CEO buys his own gold. IAUX CEO Richard Young's 1M-share open-market purchase (already +8.6% in days) stands out for conviction in a volatile junior gold market with no pre-arranged plan.
Serial ENHA accumulator. Christian Angermayer via Apeiron is now in his third distinct buying window at Enhanced Group Inc. (life sciences) within 10 days, collectively approaching $3.6M in open-market exposure.
Most-bought stocks, last 30 days
SCTX$56.3M · 3 buys, 3 insidersScribe Therapeutics Inc.
COE$47.7M · 6 buys, 2 insiders51Talk Online Education Group
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's
stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what
average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free,
and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.